Philips has announced the launch of IntelliSpace Epidemiology, a solution that optimizes the detection of healthcare-associated infections (HAIs) in the hospital. Philips Epidemiology is a single, integrated system that combines clinical informatics, bioinformatics, and genome sequencing information. Hosted on Philips HealthSuite, IntelliSpace Epidemiology will leverage deep learning and clinical analytics to genetically fingerprint pathogens and track infection transmissions quickly, as well as where they originated in the hospital.
Impact of HAIs
HAIs are a critical threat to patient safety and health system costs, resulting in higher mortality rates each year than breast cancer and prostate cancer combined and costing the U.S. healthcare system about $35 billion. IntelliSpace Epidemiology is the only decision-support solution in the U.S. that combines clinical informatics and genomic sequencing information from pathogenic bacteria, aiming to efficiently assist infection control prevention teams in identifying infection transmissions.
IntelliSpace Epidemiology combines the areas that drive infection – such as patients, clinicians, locations or equipment – with clinical informatics and bacteria genomic information. The solution can display pertinent information in intuitive dashboards that fit into a clinician’s workflow to enhance clinical actionability. This helps infection control prevention teams identify early outbreaks in the hospital so they can intervene and help to stop the spread, aiming to deliver improved patient and staff experiences, better health outcomes and lower costs of care.
“Solutions that can bring together information on healthcare-associated infections from across a hospital are vitally important to identifying and stopping infection transmissions before they progress and become dangerous to patients and care teams,” said Felix Baader, Business Leader, Monitoring & Analytics at Philips. “With IntelliSpace Epidemiology, we’re building on our leadership in clinical informatics and patient monitoring to support our overarching commitment to patient safety by piecing together all of this information to support the efficient identification of healthcare-associated infections.”
